Immediate Impact

19 standout
Sub-graph 1 of 8

Citing Papers

Recent advances in self-targeting natural product-based nanomedicines
2025 Standout
Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons
2025 Standout
2 intermediate papers

Works of Xiudi Han being referenced

Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019
2021
Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
2018

Author Peers

Author Last Decade Papers Cites
Xiudi Han 117 54 37 29 155
Gatot Soegiarto 48 56 25 29 148
Nicola Schiano Moriello 101 153 22 27 250
David Luque-Paz 55 60 50 28 216
Wilson E. Sadoh 71 37 28 24 145
James Tollitt 45 35 24 20 168
AG Bakari 64 41 23 37 227
J. A. Forbes 86 50 28 27 196
Silvius Negoiţă 71 46 26 23 175
S. C. Arya 68 27 37 33 177
Ashrit Multani 85 76 11 23 191

All Works

Loading papers...

Rankless by CCL
2026